Active Pharmaceutical Ingredient

Panitumumab — CAS 142601-70-1 API Manufacturer & Supplier in India

Also known as: Vectibix (brand); ABX-EGF; Anti-epidermal growth factor receptor antibody

GMP Certified IP / BP / USP Anti-EGFR Monoclonal Antibody / Antineoplastic Aurangabad, India
Panitumumab API Supplier Manufacturer Aurangabad Maharashtra India — Mediocon Inc
Panitumumab IP / BP / USP  |  GMP Certified  |  Mediocon Inc, Maharashtra, India
CAS No: 142601-70-1

Product Overview

Panitumumab is a fully human IgG2 monoclonal antibody that binds specifically to the epidermal growth factor receptor (EGFR) and inhibits downstream signaling. It is approved for the treatment of EGFR-expressing metastatic colorectal cancer. Mediocon Inc manufactures this biologic API at its GMP-certified facility in Aurangabad, Maharashtra, India.

Therapeutic Applications
  • Treatment of EGFR-expressing metastatic colorectal carcinoma
  • First-line treatment of RAS wild-type metastatic colorectal cancer (combined with FOLFOX)
  • Used in patients who failed prior chemotherapy regimens
  • Targeted therapy in precision oncology protocols

Technical Specifications

ParameterSpecification
CAS Number142601-70-1
Molecular FormulaC6462H9948N1716O1993S42
Molecular Weight~149,000 g/mol
GradeIP / BP / USP
CategoryAnti-EGFR Monoclonal Antibody / Antineoplastic
AppearanceWhite to off-white lyophilized powder
SolubilityFreely soluble in water, slightly soluble in phosphate buffer
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch NoPANT24032026
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Quality & Compliance

  • GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
  • Full pharmacopoeial compliance: IP / BP / USP standards
  • Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
  • Stringent in-process quality control at every manufacturing stage
  • HPLC purity testing and spectroscopic identification (IR, NMR)
  • Cold-chain and controlled-environment storage facilities available
  • Exported to 40+ countries with full regulatory support

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Panitumumab — CAS 142601-70-1 (CAS 142601-70-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Panitumumab — CAS 142601-70-1 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Panitumumab — CAS 142601-70-1 API

What is the minimum order quantity for Panitumumab — CAS 142601-70-1 API?
Mediocon Inc supplies Panitumumab — CAS 142601-70-1 with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Panitumumab — CAS 142601-70-1 does Mediocon supply?
We supply Panitumumab — CAS 142601-70-1 conforming to IP / BP / USP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Panitumumab — CAS 142601-70-1 API?
Every shipment of Panitumumab — CAS 142601-70-1 comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Panitumumab — CAS 142601-70-1 bulk orders?
Standard lead time for Panitumumab — CAS 142601-70-1 is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?